Browse studies

Find your next paid study

4 recruiting studies matching your filters

A Phase 1, Open-Label, Safety, Reactogenicity, and Immunogenicity Trial of RVX-sCPD9, a Live-Attenuated SARS-CoV-2, as a Booster Vaccine, Via the Intranasal Route in Previously Vaccinated Adults

This phase 1 clinical trial will evaluate the safety, reactogenicity, and immunogenicity of RVX-sCPD9, given Intranasally (IN), as a booster dose to previously…

COVID -19

Estimated

~$10 – $5,625

National Institute of Allergy and Infectious Diseases (NIAID)NCT07703475

Phase 1

A Phase 1a/b Randomized, Double-Blind, Placebo-Controlled Dose Escalation Study Evaluating MDX2301 in Healthy Adults and Adults at Higher Risk for Severe COVID-19

This first-in-human study is designed to evaluate the safety, tolerability, pharmacokinetics, anti-drug antibodies, and neutralizing activity of MDX2301 admini…

COVID -19COVID-19 (Prevention)

Estimated

~$10 – $8,750

ModeX Therapeutics, An OPKO Health CompanyNCT07445971

PREVENT: Preparedness Through Respiratory Virus Epidemiology and Community Engagement

The CHARM network will be established through three primary institutions-Beth Israel Deaconess Medical Center (BIDMC), the University of California San Diego (…

Respiratory Infection VirusCOVID -19RSV+1 more

Estimated

~$10 – $750

University of California, San DiegoNCT07147517

Observational

Clinical Validation of the Aptitude Medical Systems Metrix Respiratory Panel Test in At-Home/Non-Laboratory Settings

The Metrix Respiratory Panel Test will be evaluated for use in Non-Laboratory settings in a home testing environment utilizing the clinical study design descri…

COVID -19Influenza AInfluenza B+3 more

Estimated

~$10 – $7,500

Aptitude Medical SystemsNCT07217639